Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2019 Sep 2.

Published in final edited form as: Bioorg Med Chem. 2018 Jun 12;26(14):3899–3908. doi: 10.1016/j.bmc.2018.06.010

Table 2.

GI₅₀ of BIDs against colorectal cancer cell lines.

Entry	Comp.	GI₅₀ (μM)^a
Entry	Comp.	SW620	HT29
1	7a	47.60 ± 3.76	51.30 ± 5.29
2	7b	44.05 ± 7.37	49.52 ± 6.86
3	7c	53.46 ± 4.63	52.80 ± 5.90
4	7d	46.03 ± 4.61	43.73 ± 7.59
5	7e	46.89 ± 7.16	57.20 ± 5.25
6	7f	57.87 ± 5.25	61.27 ± 7.42
7	7g	23.78 ± 4.06	24.13 ± 3.88
8	7h	52.70 ± 5.94	59.80 ± 6.65
9	7i	69.70 ± 7.14	74.30 ± 4.32
10	7j	> 100	> 100
11	7k	48.90 ± 6.06	52.30 ± 5.82
12	7l	> 100	> 100
13	7m	> 100	> 100
14	7n	> 100	> 100

^a

Each GI₅₀ value was calculated from 3 independent experiments conducted in sextuplicate.